The Prevalence and Prognostic and Clinicopathological Value of PD-L1 and PD-L2 in Renal Cell Carcinoma Patients: a Systematic Review and Meta-Analysis Involving 3,389 Patients
TRANSLATIONAL ANDROLOGY AND UROLOGY（2020）
关键词
Immune checkpoint,prognostic biomarker,programmed cell death ligand 1 (PD-L1),programmed cell death-legend 2 (PD-L2),renal cell carcinoma (RCC)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要